Differentiation of Bone Marrow Mesenchymal Stem Cells to Cardiomyocyte-Like Cells Is Regulated by the Combined Low Dose Treatment of Transforming Growth Factor-β1 and 5-Azacytidine

Figure 5

Flow cytometric analysis of differentiation potential of BMMSCs. (a) Graph showing the proportion of positive cells after staining with the cTnI in the different treatment groups and uninduced groups. (b) Histograms showing the proportion of positive cells after staining with the cTnI in treated and uninduced BMMSCs. Results are expressed as the means ± SEM. versus control group; versus TGF-β1 group; versus 5-AZA group; versus 5-AZA group; versus combined treatment group ().

(a)

(b)